+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vical Inc - logo

Vical Incorporated is a biopharmaceutical company that develops products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), a therapeutic vaccine and prophylactic for herpes simplex virus type 2 and VL-2397 antifungal. The company was founded in 1987 and is headquartered in San Diego, California.

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020 - Product Thumbnail Image

Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020

  • Report
  • June 2020
  • 500 Pages
From
Hepatitis Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2018

  • Report
  • June 2018
  • 133 Pages
From
Global DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Global DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 172 Pages
From
Middle East and Africa DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Middle East and Africa DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 72 Pages
From
Latin America DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Latin America DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 73 Pages
From
North America DNA Vaccines Market 2019-2027 - Product Thumbnail Image

North America DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 88 Pages
From
Europe DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Europe DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 83 Pages
From
Asia-Pacific DNA Vaccines Market 2019-2027 - Product Thumbnail Image

Asia-Pacific DNA Vaccines Market 2019-2027

  • Report
  • August 2019
  • 88 Pages
From
2019 Genital Herpes R&D Pipeline Drugs, Companies, Trials and Developments - Product Thumbnail Image

2019 Genital Herpes R&D Pipeline Drugs, Companies, Trials and Developments

  • Report
  • March 2019
  • 67 Pages
From
Herpes Simplex - Market Insight, Epidemiology and Market Forecast - 2027 - Product Thumbnail Image

Herpes Simplex - Market Insight, Epidemiology and Market Forecast - 2027

  • Drug Pipelines
  • April 2018
  • 169 Pages
From
US DNA Vaccine Market 2019-2025 - Product Thumbnail Image

US DNA Vaccine Market 2019-2025

  • Report
  • February 2020
From
North American DNA Vaccine Market 2019-2025 - Product Thumbnail Image

North American DNA Vaccine Market 2019-2025

  • Report
  • February 2020
From
Aspergillosis Drug Pipeline Report 2020 - Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs - Product Thumbnail Image

Aspergillosis Drug Pipeline Report 2020 - Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

  • Drug Pipelines
  • October 2019
  • 80 Pages
From
2019 Cytomegalovirus (HHV-5) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - Product Thumbnail Image

2019 Cytomegalovirus (HHV-5) Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • Report
  • April 2019
  • 118 Pages
From
Global Subunit Vaccine Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global Subunit Vaccine Market Research and Forecast, 2018-2023

  • Report
  • November 2018
From
Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Echinocandins, Polyenes, Allyamines), By Indication (Dermatophytosis, Aspergillosis, Candidiasis), and Segment Forecasts, 2018 - 2025

  • Report
  • December 2018
  • 100 Pages
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • January 2018
  • 10 Pages
From
Aspergillosis Drug Development Pipeline Study, H2 2018 - Product Thumbnail Image

Aspergillosis Drug Development Pipeline Study, H2 2018

  • Report
  • August 2018
  • 90 Pages
From
Global DNA Vaccine Market Research and Forecast, 2018-2023 - Product Thumbnail Image

Global DNA Vaccine Market Research and Forecast, 2018-2023

  • Report
  • April 2018
From
2019 Aspergillosis R&D Pipeline Drugs, Companies, Trials and Developments - Product Thumbnail Image

2019 Aspergillosis R&D Pipeline Drugs, Companies, Trials and Developments

  • Report
  • March 2019
  • 75 Pages
From
Loading Indicator
adroll